———. 2011a. General guidance for stakeholders on the evaluation of article 13.1, 13.5 and 14 health claims. European Food Safety Authority Journal 9(4):2135. http://www.efsa.europa.eu/en/efsajournal/doc/2135.pdf.

———. 2011b. Guidance on the scientific requirements for health claims related to gut and immune function. European Food Safety Authority Journal 9(4):1984. http://www.efsa.europa.eu/en/nda/guidelines.htm.

FAO-WHO (Food and Agriculture Organization-World Health Organization). 2002. Guidelines for the evaluation of probiotics in food. ftp://ftp.fao.org/es/esn/food/wgreport2.pdf.

FDA (Food and Drug Administration). 2011a. Advancing regulatory science at FDA: A strategic plan. http://www.fda.gov/ScienceResearch/SpecialTopics/RegulatoryScience/UCM267719.htm.

———. 2011b. Draft guidance for industry: Dietary supplements: New dietary ingredient notifications and related issues. http://www.fda.gov/food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/DietarySupplements/UCM257563.htm.

FTC (Federal Trade Commission). 2001. Dietary supplements: An advertising guide for industry. http://business.ftc.gov/documents/bus09-dietary-supplements-advertising-guide-industry.

Hempel, S., S. Newberry, A. Ruelaz, Z. Wang, J. N. V. Miles, M. J. Suttorp, B. Johnsen, R. Shanman, W. Slusser, N. Fu, A. Smith, B. Roth, J. Polak, A. Motala, T. Perry, and P. G. Shekelle. 2011. Safety of probiotics to reduce risk and prevent or treat disease. Evidence report/technology assessment No. 200 (prepared by the Southern California Evidence-Based Practice Center under Contract No. 290-2007-10062-1). AHRQ Publication No. 11-e007. Rockville, MD: Agency for Healthcare Research and Quality.

Ibrahim, F., S. Ruvio, L. Granlund, S. Salminen, M. Viitanen, and A. C. Ouwehand. 2010. Probiotics and immunosenescence: Cheese as a carrier. Federation of European Microbiological Societies Immunology and Medical Microbiology 59(1):53-59.

Leyer, G. J., S. Li, M. E. Mubasher, C. Reifer, and A. C. Ouwehand. 2009. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124(2):e172-e179.

Makelainen, H., S. Forssten, K. Olli, L. Granlund, N. Rautonen, and A. C. Ouwehand. 2009. Probiotic lactobacilli in a semi-soft cheese survive in the simulated human gastrointestinal tract. International Dairy Journal 19(11):675-683.

Pineiro, M., N. G. Asp, G. Reid, S. Macfarlane, L. Morelli, O. Brunser, and K. Tuohy. 2008. FAO technical meeting on prebiotics. Journal of Clinical Gastroenterology 42(Suppl 3, Pt 2):S156-S159.

Shu, Q., H. Lin, K. J. Rutherfurd, S. G. Fenwick, J. Prasad, P. K. Gopal, and H. S. Gill. 2000. Dietary Bifidobacterium lactis (hn019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiology and Immunology 44(4):213-222.

van Loveren, H., Y. Sanz, and S. Salminen. 2012. Health claims in Europe: Probiotics and prebiotics as case examples. Annual Review of Food Science and Technology 3:247-261.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement